Transmission dynamics of carbapenemase-producing Klebsiella pneumoniae and anticipated impact of infection control strategies in a surgical unit

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Sypsa, Vana ^a   Psichogiou, Mina ^b   Bouzala, Georgia Aikaterina ^b   Hadjihannas, Linos ^b   Hatzakis, Angelos ^a   Daikos, Georgios L ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEMASE; CEPHALOSPORIN DERIVATIVE; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM ISOLATE; COMPLIANCE (PHYSICAL); CONTROLLED STUDY; ENZYME SYNTHESIS; GREECE; HAND WASHING; HOSPITAL ADMISSION; HUMAN; HYGIENE; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE INFECTION; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; OBSERVATIONAL STUDY; PREVALENCE; PROSPECTIVE STUDY; TERTIARY HEALTH CARE;

BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS INFECTION; ENDEMIC DISEASES; EPIDEMIOLOGICAL MONITORING; GUIDELINE ADHERENCE; HAND DISINFECTION; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MODELS, BIOLOGICAL; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PROSPECTIVE STUDIES; TERTIARY CARE CENTERS;

KLEBSIELLA PNEUMONIAE;

EID: 84864472124     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041068     Document Type: Article

References (38)

1. Schwaber MJ, Carmeli Y, ((2008)) Carbapenem-resistant Enterobacteriaceae: a potential threat. Jama 300:: 2911--2913.
2. Nordmann P, Cuzon G, Naas T, ((2009)) The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9:: 228--236.
3. Cornaglia G, Giamarellou H, Rossolini GM, ((2011)) Metallo-beta-lactamases: a last frontier for beta-lactams? Lancet Infect Dis 11:: 381--393.
4. Grundmann H, Livermore DM, Giske CG, Canton R, Rossolini GM,et al. (2010) Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill 15.
5. Wernli D, Haustein T, Conly J, Carmeli Y, Kickbusch I, et al. ((2011)) A call for action: the application of The International Health Regulations to the global threat of antimicrobial resistance. PLoS Med 8:: e1001022.
6. Queenan AM, Bush K (2007) Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 20: 440-458, table of contents.
7. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, et al. ((2008)) Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 52:: 1028--1033.
8. Daikos GL, Petrikkos P, Psichogiou M, Kosmidis C, Vryonis E, et al. ((2009)) Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother 53:: 1868--1873.
9. Bratu S, Landman D, Haag R, Recco R, Eramo A, et al. ((2005)) Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 165:: 1430--1435.
10. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP, ((2008)) Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 29:: 1099--1106.
11. Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, et al. ((2012)) Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 18:: 54--60.
12. Neuner EA, Yeh JY, Hall GS, Sekeres J, Endimiani A, et al. ((2011)) Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Diagn Microbiol Infect Dis 69:: 357--362.
13. Austin DJ, Bonten MJ, Weinstein RA, Slaughter S, Anderson RM, ((1999)) Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci U S A 96:: 6908--6913.
14. Grundmann H, Hori S, Winter B, Tami A, Austin DJ, ((2002)) Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: fitting a model to the data. J Infect Dis 185:: 481--488.
15. Cooper BS, Medley GF, Scott GM, ((1999)) Preliminary analysis of the transmission dynamics of nosocomial infections: stochastic and management effects. J Hosp Infect 43:: 131--147.
16. Cooper BS, Medley GF, Stone SP, Kibbler CC, Cookson BD, et al. ((2004)) Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc Natl Acad Sci U S A 101:: 10223--10228.
17. D'Agata EM, Horn MA, Webb GF, ((2002)) The impact of persistent gastrointestinal colonization on the transmission dynamics of vancomycin-resistant enterococci. J Infect Dis 185:: 766--773.
18. McBryde ES, Pettitt AN, McElwain DL, ((2007)) A stochastic mathematical model of methicillin resistant Staphylococcus aureus transmission in an intensive care unit: predicting the impact of interventions. J Theor Biol 245:: 470--481.
19. Lipsitch M, Bergstrom CT, Levin BR, ((2000)) The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc Natl Acad Sci U S A 97:: 1938--1943.
20. Forrester M, Pettitt AN, ((2005)) Use of stochastic epidemic modeling to quantify transmission rates of colonization with methicillin-resistant Staphylococcus aureus in an intensive care unit. Infect Control Hosp Epidemiol 26:: 598--606.
21. Wang X, Xiao Y, Wang J, Lu X, ((2012)) A mathematical model of effects of environmental contamination and presence of volunteers on hospital infections in China. J Theor Biol 293:: 161--173.
22. Grundmann H, Hellriegel B, ((2006)) Mathematical modelling: a tool for hospital infection control. Lancet Infect Dis 6:: 39--45.
23. Bonten MJ, Austin DJ, Lipsitch M, ((2001)) Understanding the spread of antibiotic resistant pathogens in hospitals: mathematical models as tools for control. Clin Infect Dis 33:: 1739--1746.
24. VatopoulosA (2008) High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece-a review of the current evidence. Euro Surveill 13.
25. Giakkoupi P, Papagiannitsis CC, Miriagou V, Pappa O, Polemis M, et al. ((2011)) An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10). J Antimicrob Chemother 66:: 1510--1513.
26. Sax H, Allegranzi B, Chraiti MN, Boyce J, Larson E, et al. ((2009)) The World Health Organization hand hygiene observation method. Am J Infect Control 37:: 827--834.
27. Sax H, Allegranzi B, Uckay I, Larson E, Boyce J, et al. ((2007)) 'My five moments for hand hygiene': a user-centred design approach to understand, train, monitor and report hand hygiene. J Hosp Infect 67:: 9--21.
28. Tsakris A, Poulou A, Themeli-Digalaki K, Voulgari E, Pittaras T, et al. ((2009)) Use of boronic acid disk tests to detect extended- spectrum beta-lactamases in clinical isolates of KPC carbapenemase-possessing enterobacteriaceae. J Clin Microbiol 47:: 3420--3426.
29. Psichogiou M, Tassios PT, Avlamis A, Stefanou I, Kosmidis C, et al. ((2008)) Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey. J Antimicrob Chemother 61:: 59--63.
30. Larson EL, Strom MS, Evans CA, ((1980)) Analysis of three variables in sampling solutions used to assay bacteria of hands: type of solution, use of antiseptic neutralizers, and solution temperature. J Clin Microbiol 12:: 355--360.
31. Bootsma MC, Bonten MJ, Nijssen S, Fluit AC, Diekmann O, ((2007)) An algorithm to estimate the importance of bacterial acquisition routes in hospital settings. Am J Epidemiol 166:: 841--851.
32. Anderson RM, May RM (1991) Infectious diseases of humans: dynamics and control. Oxford and New York: Oxford University Press.
33. Daikos GL, Vryonis E, Psichogiou M, Tzouvelekis LS, Liatis S, et al. ((2010)) Risk factors for bloodstream infection with Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase. J Antimicrob Chemother 65:: 784--788.
34. Patel N, Harrington S, Dihmess A, Woo B, Masoud R, et al. ((2011)) Clinical epidemiology of carbapenem-intermediate or-resistant Enterobacteriaceae. J Antimicrob Chemother 66:: 1600--1608.
35. Kaki R, Elligsen M, Walker S, Simor A, Palmay L, et al. ((2011)) Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother 66:: 1223--1230.
36. Schwaber MJ, Lev B, Israeli A, Solter E, Smollan G, et al. ((2011)) Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 52:: 848--855.
37. Kassis-Chikhani N, Saliba F, Carbonne A, Neuville S, Decre D,et al. (2010) Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004. Euro Surveill 15.
38. Lemmen SW, Hafner H, Zolldann D, Stanzel S, Lutticken R, ((2004)) Distribution of multi-resistant Gram-negative versus Gram-positive bacteria in the hospital inanimate environment. J Hosp Infect 56:: 191--197.